Clinical trial
Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction…
NCT00141726 · University of Michigan Rogel Cancer Center, Other · Completed
Key facts
| NCT number | NCT00141726 |
|---|---|
| Title | Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant |
| Official title | Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Sub-Acute Pulmonary Dysfunction Following Allogeneic Stem Cell Transplantation. A Phase II Study |
| Lead sponsor | University of Michigan Rogel Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Injury, Acute, Respiratory Distress Syndrome, Adult, Bronchiolitis Obliterans |
| Intervention type | Drug |
| Interventions | Etanercept |
| Enrollment | 34 |
| Start date | Oct 1, 2003 |
| Primary completion | Jul 1, 2008 |
| Completion | Feb 1, 2009 |
| First posted | Sep 1, 2005 |
| Last update posted | Dec 3, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: